Navigation Links
Generex Announces $3.0 Million Capital Investment
Date:1/25/2011

oking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not.  Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement.  No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements.  Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.  Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinical trials or to commence any particular phase of clinical trials.  Because of this, statements regarding the expected timing of clinical trials or ultimate regulatory approval cannot be regarded as actual predictions of when Generex will obtain regulatory approval for any "phase" of clinical trials or when it will obtain ultimate regulatory approval by a particular regulatory agency.  Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.


'/>"/>
SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Generex Provides Additional Details for October 21st Live Video Webcast
2. Generex Common Stock to be Quoted on the OTCQB Under the Symbol GNBT Beginning Thursday, October 21, 2010
3. Generex Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
4. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
5. Generex Plans Rights Offering to Stockholders Following Reverse Stock Split
6. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
7. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
9. Spherix Announces Closing of Registered Direct Offering of $2.77 Million in Common Stock and Warrants
10. Amgen Announces Webcast of 2010 Fourth Quarter and Full Year Financial Results
11. Sensus Healthcare Announces New Professional Skin Care Line - Sensus Skin Solutions™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Richardson, Texas (PRWEB) October 20, 2014 ... today announced that a team from Iowa State University ... * design contest. Using a Convey HC-2ex, the team’s ... than 14 times faster than the second place finisher. ... academic world embarked upon the month long challenge, using ...
(Date:10/20/2014)... PureTech , a science and ... problems, announced today the closing of a $55 ... Invesco Perpetual, a $120 Billion group of funds. ... existing pipeline forward and to advance new healthcare ... creativity to really go for the big ideas ...
(Date:10/19/2014)... 2014 OCTOBER 20-22, 2014: ... ABIM will take place at the ... ABIM 2014 is now available at ... companies and organizations from all over the ... on the latest products and developments on ...
(Date:10/19/2014)... report "Chocolate, Cocoa Beans, Lecithin, Sugar and Vanilla Market ... (2011 - 2016)," analyzes the chocolate market by ... market drivers, restraints, and opportunities for the chocolate market ... chocolate market is expected to grow from $83.2 billion ... CAGR of 2.7% from 2011 to 2016. , Get ...
Breaking Biology Technology:Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 2Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 4
... N.J., Sept. 17 Medarex, Inc.,(Nasdaq: MEDX ) ... the UBS,Global Life Sciences Conference at 4:30 p.m. Eastern ... webcast live and will be available in,the Investor Relations ... archived edition of the presentation will be available following ...
... Former Chair Of Psychology Department At Harvard University,Joins Panel Of ... ... Neurological Testing Company, BERKELEY, Calif., Sept. 17 NeuroFocus, ... for marketing,research, announced that professor Stephen Kosslyn, Ph.D. has joined ...
... LOUIS, Sept. 17 Sigma-Aldrich Corporation,(Nasdaq: SIAL ) ... Sciences,Conference on Wednesday, September 24th at 8:30 AM ET ... may listen via live audio broadcast over the,Internet available ... to access this file. For the webcast on, http://ir.sigmaaldrich.com ...
Cached Biology Technology:Neurofocus Appoints Stephen Kosslyn to Its Advisory Board 2
(Date:10/17/2014)... . To date, ... overdoses, doctors are often limited to supportive therapy such as ... combination of drugs involved. So what can be done if ... ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences ... question. "The task was to develop an agent that could ...
(Date:10/16/2014)... synthesis of recent research findings to inform their management ... states. , The Ecology and Management of Moist ... of the Relevant Biophysical Science and Implications for Future ... U.S. Forest Service,s Pacific Northwest Research Station, is a ... synthesis of the large body of scientific information on ...
(Date:10/16/2014)... tract infections and worldwide claims the lives of ... Ghent University have succeeded in developing a promising ... , Xavier Saelens (VIB/UGent): "We discovered a ... the development of a novel approach to vaccination ... numerous small children and elderly people." , ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3New report synthesizes best available science on management of moist mixed-conifer forests 2New perspectives for development of an RSV vaccine 2
... A great deal of science learning takes place ... for example, and through TV programs, books, and online ... new from the National Research Council, recommends ways museum ... foster science learning for people of all ages, backgrounds, ...
... An Australian method for assessing the environmental impact of ... agencies worldwide. Aspects of the ,ecological risk assessment, ... Ecuador, and the Western and Central Pacific, and by ... The method was developed in research led by Dr ...
... Two junior researchers from Ludwig-Maximilians-Universitt (LMU) in ... the European Research Council (ERC). Professor Jens Michaelis, ... David Vhringer, Institute of Immunology, shall receive grants ... five years. With its Starting Grant, the ERC ...
Cached Biology News:World interest in Australian fishery impact test 2LMU Munich researchers highly endowed with EU funding 2
Designed for use with any of the Agencourt kits in tube format....
... (4,6-diamidine-2-phenylindole, dihydrochloride) is a fluorescent ... blue in color. The bright ... to red fluorochromes such as ... R-Phycoerythrin. DAPI can be used ...
... cytochrome P450 (CYP450) metabolite postulated to play ... cerebral vasculature. In rat cerebral microvessels, 20-HETE ... vasoconstriction. 20-HETE is excreted mainly as the ... (20-40 pg/ml in human urine) is about ...
... APAgene kits are designed to rapidly ... using our patented APA Technology. APAgene provides ... competitive price. All necessary ingredients are provided ... can be used for gap filling, localized ...
Biology Products: